Plavix Settlement Updated To Appease FTC
Law360 (June 26, 2006, 12:00 AM EDT) -- In a case that could influence how the U.S. Federal Trade Commission rules on future settlement agreements over generic drugs, Bristol-Myers Squibb, Sanofi-Aventis and Apotex have altered their settlement over the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
